Tenet Reports Results for the Third Quarter Ended September 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Tenet Healthcare (THC) Tops Q3 EPS by 23c; Lower Outlook
November 6, 2017 4:23 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of ($0.17), $0.23 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $4.59 billion versus the consensus estimate of $4.68 billion.
GUIDANCE:
Tenet Healthcare sees FY2017 EPS of $0.59-$0.74, versus the consensus of $0.76.
Reported a net loss from continuing operations attributable to Tenet shareholders of $366 million or $3.63 per diluted share. Adjusted diluted loss per share from continuing operations was $0.17.Adjusted EBITDA was $507 million... More


